Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Tevra Brands LLC is currently handling 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action suggests a very focused or perhaps early-stage interaction with the patent office for its current pharmaceutical-related filings. The company's immediate prosecution efforts are centered on this one specific matter, requiring a precise response to the examiner's concerns.
The administrative scope is limited to 1 distinct examiner and 1 distinct art unit. This indicates that the company's current legal focus is highly localized within a single technical department of the USPTO. GRANO, ERNESTO ARTURIO is the busiest examiner for the portfolio, responsible for 1 busiest examiner pending action. As the only examiner currently reviewing the company's pending work, this individual's specific feedback and examination pace will be the primary factor in the portfolio's near-term progress. Practitioners should focus on the specific technical requirements of this one art unit to move the application toward allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GRANO, ERNESTO ARTURIO | 1 | 61.2% | +25.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18825860 | METHOD FOR ADMINISTERING A FORMULATION TO AN ANIMAL | GRANO, ERNESTO ARTURIO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18825860 | METHOD FOR ADMINISTERING A FORMULATION TO AN ANIMAL | GRANO, ERNESTO ARTURIO | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18825860 | METHOD FOR ADMINISTERING A FORMULATION TO AN ANIMAL | GRANO, ERNESTO ARTURIO | 1624 | §102§103 | Final Rejection | — | Pending | Sep 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTevra Brands LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ernesto Arturio Grano has the most, with 1 of Tevra Brands LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
